Latest News

Updated guidelines on PA call for expanded screening, treatment, and monitoring, creating opportunities for pharmacists to screen all patients with hypertension.

Cardiotoxic signals released from the kidneys may drive cardiovascular risk in patients with chronic kidney disease, opening the door to earlier detection and targeted treatment.

Recent research reveals no link between menopause hormone therapy and dementia risk, urging further studies to clarify its effects on cognitive health.

Effective medication management requires active patient involvement and understanding.

The FDA expands Cerezyme's approval for treating non-CNS symptoms of type 3 Gaucher disease, marking a significant advancement in patient care.

The study found that anxiety and depression in those with Parkinson disease were significantly associated with fatigue severity.

FDA's draft guidance on MRD and CR as end points accelerates multiple myeloma therapy approvals, enhancing patient access and transforming oncology practices.

New research reveals how specific gut bacteria in infants may reduce the risk of allergies and asthma, offering potential preventive strategies.

The American Heart Association (AHA) has released new guidance highlighting numerous obstacles that individuals with obesity face when treating and managing their condition, including limited access to healthy foods and weight stigma.

Various OTC analgesic and anesthetic products can be effective in providing prompt, temporary relief from discomfort.

Explore how radio frequency identification (RFID) technology enhances medication safety, operational efficiency, and patient care in health care and pharmacy settings.

Interest in intravenous push administration of antibiotics is regaining popularity as fluid shortages arise.

Research reveals COVID-19's lasting effects on brain health, highlighting cognitive impairments in patients with long COVID even after recovery.

Recent research links depression to increased risk of Lewy body dementia and Parkinson disease, emphasizing the need for early detection and awareness.

Pharmacists are essential in guiding patients taking TNF inhibitors regarding supplement use, the risks of "immune boosters," and potential immunomodulatory therapy interactions.

Innovative immunotherapy strategies, like linvoseltamab, show promise in treating multiple myeloma, potentially reducing reliance on traditional transplants.

Patients with chronic kidney disease (CKD) send miRNA extracellular vesicles to the heart, contributing to the pathogenesis of heart failure.

The short message service (SMS) text reminders were targeted toward vulnerable patient populations and consequently reduced rates of readmission to the hospital.

Using wildcard hard-stop pharmacy preparation instructions in the electronic health record system significantly improved REMs documentation compliance at our institution.

Hospital pharmacies enhance efficiency and reduce waste through innovative medication management and RFID technology, ensuring optimal patient care and safety.

Rocatinlimab shows promise in treating moderate-to-severe atopic dermatitis, offering significant symptom relief.